Switch theme
Sign up to access all valuation multiples
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals.
2002
84
LTM Revenue $5.4M
LTM EBITDA -$10.1M
$132M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nightingale Health has a last 12-month revenue of $5.4M and a last 12-month EBITDA of -$10.1M.
In the most recent fiscal year, Nightingale Health achieved revenue of $4.7M and an EBITDA of -$9.9M.
Nightingale Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nightingale Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $4.5M | $4.7M | XXX | XXX | XXX |
| Gross Profit | $1.4M | $3.9M | XXX | XXX | XXX |
| Gross Margin | 31% | 82% | XXX | XXX | XXX |
| EBITDA | -$12.2M | -$9.9M | XXX | XXX | XXX |
| EBITDA Margin | -272% | -211% | XXX | XXX | XXX |
| Net Profit | -$17.3M | -$19.4M | XXX | XXX | XXX |
| Net Margin | -385% | -415% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Nightingale Health's stock price is EUR 3 (or $3).
Nightingale Health has current market cap of EUR 180M (or $194M), and EV of EUR 122M (or $132M).
See Nightingale Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $132M | $194M | XXX | XXX | XXX | XXX | $-0.29 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Nightingale Health has market cap of $194M and EV of $132M.
Nightingale Health's trades at 24.4x LTM EV/Revenue multiple, and -13.0x LTM EBITDA.
Analysts estimate Nightingale Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Nightingale Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $132M | XXX | XXX | XXX |
| EV/Revenue | 25.6x | XXX | XXX | XXX |
| EV/EBITDA | -13.4x | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNightingale Health's NTM/LTM revenue growth is 51%
Nightingale Health's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Nightingale Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Nightingale Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Nightingale Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -192% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -19% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -141% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 18% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 39% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 494% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
| Cogstate | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
| Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nightingale Health acquired XXX companies to date.
Last acquisition by Nightingale Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Nightingale Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Nightingale Health founded? | Nightingale Health was founded in 2002. |
| Where is Nightingale Health headquartered? | Nightingale Health is headquartered in Finland. |
| How many employees does Nightingale Health have? | As of today, Nightingale Health has 84 employees. |
| Who is the CEO of Nightingale Health? | Nightingale Health's CEO is Mr. Teemu Suna. |
| Is Nightingale Health publicy listed? | Yes, Nightingale Health is a public company listed on HEL. |
| What is the stock symbol of Nightingale Health? | Nightingale Health trades under HEALTH ticker. |
| When did Nightingale Health go public? | Nightingale Health went public in 2021. |
| Who are competitors of Nightingale Health? | Similar companies to Nightingale Health include e.g. Beamtree, Cogstate, Echo IQ, Impedimed. |
| What is the current market cap of Nightingale Health? | Nightingale Health's current market cap is $194M |
| What is the current revenue of Nightingale Health? | Nightingale Health's last 12-month revenue is $5.4M. |
| What is the current EBITDA of Nightingale Health? | Nightingale Health's last 12-month EBITDA is -$10.1M. |
| What is the current EV/Revenue multiple of Nightingale Health? | Current revenue multiple of Nightingale Health is 24.4x. |
| What is the current EV/EBITDA multiple of Nightingale Health? | Current EBITDA multiple of Nightingale Health is -13.0x. |
| What is the current revenue growth of Nightingale Health? | Nightingale Health revenue growth between 2023 and 2024 was 4%. |
| Is Nightingale Health profitable? | Yes, Nightingale Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
